Group 1 - The core point of the article is that Xinjin Power (SZ 300157) held its 15th meeting of the 6th board of directors on December 9, 2025, to review proposals related to the company's governance system [1] - For the first half of 2025, Xinjin Power's revenue composition was 83.6% from high-end equipment manufacturing and 16.4% from energy and energy services [1] - As of the report, Xinjin Power has a market capitalization of 3.6 billion yuan [1] Group 2 - The article also highlights a significant issue in the pharmaceutical industry, reporting the first case of pregabalin abuse leading to addiction in China, raising concerns about the accessibility of prescription drugs without proper medical records [1]

Group 1 - The core point of the article is that Xinjin Power (SZ 300157) held its 14th meeting of the 6th board of directors on October 26, 2025, to discuss the reappointment of the accounting firm for the fiscal year 2025 [1] - For the first half of 2025, Xinjin Power's revenue composition is as follows: high-end equipment manufacturing accounts for 83.6%, while energy and energy services account for 16.4% [1] - As of the time of reporting, Xinjin Power has a market capitalization of 3.6 billion yuan [1]

Group 1 - The company Xinjin Power (SZ 300157) announced that its 13th meeting of the 6th board of directors will be held on September 15, 2025, in Beijing, discussing the signing of an execution and settlement agreement with Chongqing Changshou Economic Development Shengshi Equity Investment Fund Partnership [1] - For the first half of 2025, Xinjin Power's revenue composition was 83.6% from high-end equipment manufacturing and 16.4% from energy and energy services [1] - As of the report date, Xinjin Power has a market capitalization of 3.7 billion yuan [1]